Almost all currently used vaccines against COVID-19 consist of either non-viral or viral nanoparticles. Here we attempt to understand the reasons behind the success of such advanced nanoscale vaccine technologies compared with clinically established conventional vaccines, and the lessons to be learnt from this potentially transformative development in the adoption and acceptance of nanotechnology for medicine.

中文翻译：

---

从针对 COVID-19 的纳米级疫苗中获得成功的原因和经验教训

目前使用的几乎所有针对 COVID-19 的疫苗都由非病毒或病毒纳米颗粒组成。在这里，我们试图了解与临床上建立的常规疫苗相比，这种先进的纳米级疫苗技术成功背后的原因，以及从这种潜在的变革性发展中吸取的教训，即纳米技术在医学上的采用和接受。